Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blinded, Randomized, Active Control Comparative, Parallel-designed, Phase III Clinical Trial: Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Hugeltox Inj." In Essential Blepharospasm Running Parallel With Phase I Study

NCT01791881 is registered in ClinicalTrials.gov with Hugel as lead sponsor.

NCT NCT01791881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01791881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blinded, Randomized, Active Control Comparative, Parallel-designed, Phase III Clinical Trial: Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Hugeltox Inj." In Essential Blepharospasm Running Parallel With Phase I Study
Lead sponsor
Hugel
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2008
Completion date
July 31, 2009
Enrollment
172 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

essential blepharospasm